- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04183400
Safety Awareness For Empowerment (SAFE): An RCT With Young People Experiencing Homelessness (SAFE)
September 25, 2020 updated by: Kimberly Bender, University of Denver
The SAFE study examines the effects of brief mindfulness-based cognitive-behavioral intervention aimed at improving risk-related attention skills (risk detection, problem solving, assertiveness, and help seeking) in order to reduce substance use and victimization among young people (ages 18-21) experiencing homelessness.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Youth (ages 18-21) living at a local youth shelter will be recruited and randomly assigned to receive the SAFE intervention (plus usual case management) or to receive usual case management only.
Those assigned to SAFE will receive 12 mindfulness-based, cognitive-behavioral modules through a 3-day intensive group intervention provided by an agency intern and a hired project staff member.
The intervention uses mindfulness-based cognitive-behavioral approaches to augment youth attention to risk-related processes, including risk detection, problem solving, assertiveness, and help seeking skills.
It is hypothesized the intervention will result in reduced substance use and victimization and that these effects will be explained, at least in part, by improved risk-related attention skills (risk detection, problem solving, assertiveness, and help seeking skills).
Post baseline interview, participants will be randomly assigned and will participate in a posttest interview (1 week post baseline) and follow up interviews at 6-weeks, 3-months, and 6-months post baseline interview.
Study Type
Interventional
Enrollment (Actual)
244
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 80223
- Urban Peak Shelter and University of Denver
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 21 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Reside at the partnering community based youth shelter
Exclusion Criteria:
As measured by the KSADS (a semi-structured diagnostic interview administered by trained interviewers at baseline):
- presence of psychotic symptoms;
- presence of a life-threatening medical/chronic neurological illness that would prevent participation in a 4-day intervention and/or assessments;
- suicide attempt in last 6 months without current enrollment in therapy or related services to address;
- chronic self-injurious behavior/cutting without current enrollment in therapy or related services to address
- hospitalization or residential treatment for psychiatric reasons in last 6 months without current enrollment in therapy or related services to address.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Safety Awareness For Empowerment (SAFE)
Brief mindfulness-based cognitive-behavioral skill-building intervention
|
SAFE is a mindfulness-based cognitive-behavioral intervention that aims to build risk-related attention skills.
|
No Intervention: Usual case management only
Control condition receives only services as usual
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Substance use
Time Frame: Follow up at 6-weeks post baseline interview
|
The Substance use domain of the Addiction Severity Index, 5th edition will be used to assess the frequency, type and amount of substance use in the past 30 days.
This domain will be adapted to add smoking tobacco to the list of substances.
|
Follow up at 6-weeks post baseline interview
|
Substance use
Time Frame: Follow up at 3-months post baseline interview
|
The Substance use domain of the Addiction Severity Index, 5th edition will be used to assess the frequency, type and amount of substance use in the past 30 days.
This domain will be adapted to add smoking tobacco to the list of substances.
|
Follow up at 3-months post baseline interview
|
Substance use
Time Frame: Follow up at 6-months post baseline interview
|
The Substance use domain of the Addiction Severity Index, 5th edition will be used to assess the frequency, type and amount of substance use in the past 30 days.
This domain will be adapted to add smoking tobacco to the list of substances.
|
Follow up at 6-months post baseline interview
|
Victimization
Time Frame: Follow up at 6-weeks post baseline interview
|
The Juvenile Victimization Questionnaire (JVQ) will be used to asses exposure to a range of types of victimization.
|
Follow up at 6-weeks post baseline interview
|
Victimization
Time Frame: Follow up at 3-months post baseline interview
|
The Juvenile Victimization Questionnaire (JVQ) will be used to asses exposure to a range of types of victimization.
|
Follow up at 3-months post baseline interview
|
Victimization
Time Frame: Follow up at 6-months post baseline interview
|
The Juvenile Victimization Questionnaire (JVQ) will be used to asses exposure to a range of types of victimization.
|
Follow up at 6-months post baseline interview
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Substance use symptoms
Time Frame: Follow up at 6-weeks, 3-months, and 6-months post baseline interview, controlling for baseline
|
The Mini International Neuropsychiatry Interview (MINI) will be used to assess a count of the number of substance use symptoms experienced.
|
Follow up at 6-weeks, 3-months, and 6-months post baseline interview, controlling for baseline
|
Substance use disorder diagnostic criteria
Time Frame: Follow up at 6-weeks, 3-months, and 6-months post baseline interview, controlling for baseline
|
The Mini International Neuropsychiatry Interview (MINI) will be used to assess a whether the participant meets DSM diagnostic criteria for a substance use disorder
|
Follow up at 6-weeks, 3-months, and 6-months post baseline interview, controlling for baseline
|
Risk detection
Time Frame: Follow up at 1-week, 6-weeks, and 3-months post baseline interview, controlling for baseline
|
Risk detection will be assessed a set of researcher-developed Risk Vignettes that describe characters in risk situations and ask participants to identify risk cues present; measure will be proportion of risk cues identified among those present in the vignettes administered
|
Follow up at 1-week, 6-weeks, and 3-months post baseline interview, controlling for baseline
|
Help seeking intentions
Time Frame: Follow up at 1-week, 6-weeks, and 3-months post baseline interview, controlling for baseline
|
Help seeking intentions will be assessed with a modified version of the General Help Seeking Questionnaire which assesses intentions to seek help from different sources for different problems.
The original scale asks about seeking help for emotional problems and suicidal thoughts; our version was modified to ask about help seeking related to safety issues and substance use.
Higher scores indicate greater help seeking thus a more positive outcome.
|
Follow up at 1-week, 6-weeks, and 3-months post baseline interview, controlling for baseline
|
Help seeking behaviors
Time Frame: Follow up at 1-week, 6-weeks, and 3-months post baseline interview, controlling for baseline
|
Help seeking behaviors will be assessed by items from the Help Seeking Behaviors scale which ask how often youth actually sought help fro different sources of help for substance and for safety.
|
Follow up at 1-week, 6-weeks, and 3-months post baseline interview, controlling for baseline
|
Assertiveness
Time Frame: Follow up at 1-week, 6-weeks, and 3-months post baseline interview, controlling for baseline
|
Assertiveness will be assessed using the Assertion Inventory which asks how often participants engage in assertive behaviors across three domains: substance use, general, and social situations
|
Follow up at 1-week, 6-weeks, and 3-months post baseline interview, controlling for baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Kimberly Bender, PhD, University of Denver
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2015
Primary Completion (Actual)
June 1, 2020
Study Completion (Actual)
September 1, 2020
Study Registration Dates
First Submitted
November 15, 2019
First Submitted That Met QC Criteria
November 27, 2019
First Posted (Actual)
December 3, 2019
Study Record Updates
Last Update Posted (Actual)
September 28, 2020
Last Update Submitted That Met QC Criteria
September 25, 2020
Last Verified
September 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UDenverSAFE
- 1R15DA039355-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Substance Use Disorders | Cannabis Use | Alcohol Use, UnspecifiedUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of MichiganNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingSubstance Use | Substance Use Disorders | Substance DependenceUnited States
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Opioid Use | Drug Use | Substance MisuseUnited States
-
Centre for Addiction and Mental HealthUniversity of Missouri, St. LouisCompletedSubstance Use Disorders | Alcohol Use DisorderCanada
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)CompletedPTSD | Alcohol Use Disorders | Substance Use DisordersUnited States
-
Istanbul UniversityCompletedSubstance Use | Substance Use Disorders | Substance AbuseTurkey
Clinical Trials on Safety Awareness For Empowerment (SAFE)
-
University of North Carolina, Chapel HillU.S. Department of EducationCompletedSchizophrenia | Bipolar Disorder | Major Depressive DisorderUnited States
-
The New York Society for the Prevention of Cruelty...National Institutes of Health (NIH)CompletedSafe Touches: A Rigorous Evaluation of a Sexual Abuse Prevention Program for Children (Safe Touches)Child Sexual AbuseUnited States
-
Centers for Disease Control and PreventionUniversity of Illinois at Chicago; Howard Brown Health Center; Chicago Department... and other collaboratorsCompletedHIV InfectionsUnited States
-
University of California, Los AngelesDuke UniversityRecruitingSuicidal IdeationUnited States
-
Henry M. Jackson Foundation for the Advancement...University of Pennsylvania; Columbia University; United States Department of... and other collaboratorsCompletedSuicide, Attempted | SuicideUnited States
-
VA Office of Research and DevelopmentCompletedSuicideUnited States
-
Jennifer HughesAmerican Foundation for Suicide PreventionEnrolling by invitationSuicide, Attempted | Suicide | Suicide Threat | Suicide and Self-harmUnited States
-
University of FloridaCompletedMeningococcal VaccineUnited States
-
VA Office of Research and DevelopmentProvidence VA Medical CenterRecruitingBipolar Disorder | Substance Use DisordersUnited States
-
Region StockholmKarolinska InstitutetRecruitingSuicide and Self-harmSweden